US 7,531,339 B2
	Glyphosate-N-acetyltransferase (GAT) genes
Linda A. Castle, Mountain View, Calif. (US); Dan Siehl, Menlo Park, Calif. (US); Lorraine Giver, Sunnyvale, Calif. (US); Jeremy Minshull, Los Altos, Calif. (US); Cristina Ivy, Encinitas, Calif. (US); Yong Hong Chen, Foster City, Calif. (US); Nicholas B. Duck, Apex, N.C. (US); and Phillip A. Patten, Menlo Park, Calif. (US)
Assigned to Verdia, Inc., Redwood City, Calif. (US); and Pioneer Hi-Bred International, Inc., Johnston, Iowa (US)
Filed on Apr. 17, 2006, as Appl. No. 11/405,845.
Application 11/405845 is a division of application No. 10/427692, filed on Apr. 30, 2003, granted, now 7,462,481.
Application 10/427692 is a continuation in part of application No. 10/004357, filed on Oct. 29, 2001, abandoned.
Claims priority of provisional application 60/377175, filed on May 01, 2002.
Claims priority of provisional application 60/377719, filed on Apr. 30, 2002.
Claims priority of provisional application 60/244385, filed on Oct. 30, 2000.
Prior Publication US 2006/0191033 A1, Aug. 24, 2006
Int. Cl. C12N 9/10 (2006.01); C12N 5/04 (2006.01); C12N 15/82 (2006.01); C07H 21/02 (2006.01); A01H 7/00 (2006.01)

U.S. Cl. 435—193  [435/419; 435/468; 536/23.2; 800/300]

27 Claims

1. An isolated or recombinant polypeptide comprising an amino acid sequence that can be optimally aligned with SEQ ID NO:300 to generate a similarity score of at least 650 using the BLOSUM62 matrix, a gap existence penalty of 11, and a gap extension penalty of 1, wherein the polypeptide has glyphosate-N-acetyl transferase activity.